New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer
{{output}}
Background: Several biomarkers have emerged as potential prognostic and predictive markers for non-small-cell lung cancer (NSCLC). Successful inhibition of angiogenesis with the antivascular endothelial growth factor antibody, be... ...
